270 related articles for article (PubMed ID: 23764536)
1. Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate.
Pore D; Chakrabarti MK
Vaccine; 2013 Aug; 31(36):3644-50. PubMed ID: 23764536
[TBL] [Abstract][Full Text] [Related]
2. Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2-dependent manner and involvement of IL-12 and nitric oxide.
Pore D; Mahata N; Chakrabarti MK
J Biol Chem; 2012 Apr; 287(15):12589-601. PubMed ID: 22343631
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with LacVax® OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model.
Yagnik B; Sharma D; Padh H; Desai P
Vaccine; 2019 May; 37(23):3097-3105. PubMed ID: 31047673
[TBL] [Abstract][Full Text] [Related]
4. Role of Shigella flexneri 2a 34 kDa outer membrane protein in induction of protective immune response.
Mukhopadhaya A; Mahalanabis D; Chakrabarti MK
Vaccine; 2006 Aug; 24(33-34):6028-36. PubMed ID: 16765491
[TBL] [Abstract][Full Text] [Related]
5. Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model.
Pore D; Mahata N; Pal A; Chakrabarti MK
PLoS One; 2011; 6(7):e22663. PubMed ID: 21818362
[TBL] [Abstract][Full Text] [Related]
6. Outer membrane protein A (OmpA) of Shigella flexneri 2a induces TLR2-mediated activation of B cells: involvement of protein tyrosine kinase, ERK and NF-κB.
Bhowmick R; Pore D; Chakrabarti MK
PLoS One; 2014; 9(10):e109107. PubMed ID: 25286253
[TBL] [Abstract][Full Text] [Related]
7. In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri.
León Y; Zapata L; Salas-Burgos A; Oñate A
Mol Immunol; 2020 May; 121():47-58. PubMed ID: 32163758
[TBL] [Abstract][Full Text] [Related]
8. Outer Membrane Vesicles Derived from
Tian H; Li B; Xu T; Yu H; Chen J; Yu H; Li S; Zeng L; Huang X; Liu Q
Appl Environ Microbiol; 2021 Sep; 87(19):e0096821. PubMed ID: 34319809
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of an immunogenic outer membrane protein of Shigella flexneri 2a.
Pore D; Chowdhury P; Mahata N; Pal A; Yamasaki S; Mahalanabis D; Chakrabarti MK
Vaccine; 2009 Sep; 27(42):5855-64. PubMed ID: 19660587
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
[TBL] [Abstract][Full Text] [Related]
11. Towards a non-living vaccine against Shigella flexneri: from the inactivation procedure to protection studies.
Camacho AI; Souza-Rebouças J; Irache JM; Gamazo C
Methods; 2013 May; 60(3):264-8. PubMed ID: 23046911
[TBL] [Abstract][Full Text] [Related]
12. Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain.
Mitra S; Sinha R; Mitobe J; Koley H
Vaccine; 2016 Apr; 34(15):1839-46. PubMed ID: 26878295
[TBL] [Abstract][Full Text] [Related]
13. Regulated Delayed
Su H; Liu Q; Wang S; Curtiss R; Kong Q
Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
[No Abstract] [Full Text] [Related]
14. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.
Phalipon A; Tanguy M; Grandjean C; Guerreiro C; Bélot F; Cohen D; Sansonetti PJ; Mulard LA
J Immunol; 2009 Feb; 182(4):2241-7. PubMed ID: 19201878
[TBL] [Abstract][Full Text] [Related]
15. Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis.
Mitra S; Chakrabarti MK; Koley H
Vaccine; 2013 Jun; 31(31):3163-73. PubMed ID: 23684822
[TBL] [Abstract][Full Text] [Related]
16. Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection.
Kim JO; Rho S; Kim SH; Kim H; Song HJ; Kim EJ; Kim RY; Kim EH; Sinha A; Dey A; Yang JS; Song MK; Nandy RK; Czerkinsky C; Kim DW
Clin Vaccine Immunol; 2015 Apr; 22(4):381-8. PubMed ID: 25651919
[TBL] [Abstract][Full Text] [Related]
17. Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice.
Mitra S; Barman S; Nag D; Sinha R; Saha DR; Koley H
FEMS Immunol Med Microbiol; 2012 Nov; 66(2):240-50. PubMed ID: 22762732
[TBL] [Abstract][Full Text] [Related]
18.
Clarkson KA; Porter CK; Talaat KR; Frenck RW; Alaimo C; Martin P; Bourgeois AL; Kaminski RW
mSphere; 2021 Aug; 6(4):e0012221. PubMed ID: 34259559
[No Abstract] [Full Text] [Related]
19. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
Oaks EV; Turbyfill KR
Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
[TBL] [Abstract][Full Text] [Related]
20. Towards a subunit vaccine from a Shigella flexneri ΔtolR mutant.
Pastor Y; Camacho AI; Zúñiga-Ripa A; Merchán A; Rosas P; Irache JM; Gamazo C
Vaccine; 2018 Nov; 36(49):7509-7519. PubMed ID: 30420041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
